Raised serum S100B protein levels in neuropsychiatric lupus
- 1 June 2006
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (6) , 829-831
Abstract
Objective: To test serum S100B protein levels in patients with and without neuropsychiatric systemic lupus erythematosus (NPSLE) and controls. Methods: 87 patients with SLE, 23 with and 64 without neuropsychiatric involvement, and 25 control subjects were prospectively evaluated. NPSLE diagnosis was made according to the American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Serum S100B protein levels were determined with a luminescence immunoassay. Statistical analysis was performed using Mann-Whitney and Kruskal-Wallis tests. Results: Among the patients with NPSLE, 9 presented psychosis; 4, cranial neuropathy; 3, cerebrovascular disease; 1, seizures; 1, chorea; 1, peripheral polyneuropathy; 1, multiplex mononeuropathy; 3, dementia. Serum concentrations of S100B protein were significantly higher in patients with NPSLE (median 0.164 ng/ml, interquartile range 0.113–0.332) than in non-NPSLE patients (0.062 ng/ml, 0.026–0.109) and controls (0.088 ng/ml, 0.013–0.124) (p<0.001). Patients with anti-dsDNA antibodies had higher S100B protein levels (p = 0.001). No significant associations were found of lupus activity (among non-NPSLE cases), antiphospholipid antibodies, and reduced complement levels with S100B concentration. Conclusions: Serum S100B protein level is raised in NPSLE, reflecting continuing neurological damage. The association of anti-dsDNA antibodies with higher S100B protein concentration deserves further study.Keywords
This publication has 15 references indexed in Scilit:
- S100B in brain damage and neurodegenerationMicroscopy Research and Technique, 2003
- Neuropsychiatric syndromes in lupusNeurology, 2002
- Serum S100B Levels in Patients with Lupus Erythematosus: Preliminary ObservationClinical and Vaccine Immunology, 2002
- A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosusNature Medicine, 2001
- Increased serum S100B protein in schizophrenia: a study in medication-free patientsJournal of Psychiatric Research, 2001
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Controversies in lupus: nervous system involvement.Annals of the Rheumatic Diseases, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- The pathogenesis of central nervous system manifestations of systemic lupus erythematosusArthritis & Rheumatism, 1982
- A multicenter study of outcome in systemic lupus erythematosus. ii.Arthritis & Rheumatism, 1982